Results 161 to 170 of about 28,079 (244)

Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations [PDF]

, 2013
Nga Thi Thuy Nguyen, Sylvie Rato, François Clavel, Constance Delaugerre, Fabrizio Mammano   +4 more
openalex   +1 more source

Salvage therapy with an Albuvirtide-based antiretroviral regimen for multi-drug resistant HIV and drug-resistant HBV with renal impairment: a case report. [PDF]

Virol J
He Y, Liao B, Liu Y, Cao Y, Li L, Cai W.
europepmc   +1 more source

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

, 2011
Isabelle Malet, Marc Wirden, Slim Fourati, Daniele Armenia, Bernard Masquelier, Lavinia Fabeni, Sophie Sayon, Christine Katlama, Carlo Federico Perno, Vincent Cálvez, Anne‐Geneviève Marcelin, Francesca Ceccherini‐Silberstein   +11 more
openalex   +1 more source

Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013 [PDF]

, 2014
Joanne D. Stekler, Jennifer L. McKernan, Ross Milne, Kenneth Tapia, Kateryna Mykhalchenko, Sarah Holte, Janine Maenza, Claire E. Stevens, Susan E. Buskin, James I. Mullins, Lisa M. Frenkel, Ann C. Collier   +11 more
openalex   +1 more source

Noncanonical HIV drug resistance mutations: need to close existing gaps. [PDF]

AIDS
Inzaule S, Jordan MR, Fokam J, Hamers RL, Paredes R, Crowell TA, Shafer RW, Schapiro J, Rinke de Wit TF, Charurat M, Kuritzkes DR, Ndembi N.   +11 more
europepmc   +1 more source

Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes

, 2011
Kendra E. Hightower, Ruolan Wang, Felix Deanda, Brian A. Johns, Kurt Weaver, Yingnian Shen, Ginger H. Tomberlin, H. Luke Carter, Timothy M Broderick, Sigethy Scott, Takahiro Seki, Masanori Kobayashi, Mark Underwood   +12 more
openalex   +1 more source

Influence of antiretroviral therapy on frailty among people living with HIV. [PDF]

Sci Rep
Contreras Macías E, Robustillo Cortés MLA, Morillo Verdugo R.   +2 more
europepmc   +1 more source

Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France [PDF]

, 2014
Nicolas Despiégel, Anne-Geneviève Marcellin, C. Aubin, Caroline Espinas, Audrey Laurisse, Gilles Pialoux   +5 more
openalex   +1 more source

High concordance of human immunodeficiency virus-1 genotypic drug resistance generated from paired cerebrospinal fluid and plasma in antiretroviral therapy -naive or -experienced patients. [PDF]

Front Microbiol
Deng X, Li J, He R, Wen Y, Lin Y, Li L, Ling X, Hu F, Li L, Lan Y.   +9 more
europepmc   +1 more source

Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals [PDF]

, 2015
Teresa Llácer Delicado, Esther Torrecilla, África Holguín   +2 more
openalex   +1 more source